166 related articles for article (PubMed ID: 2787674)
1. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma.
Zhang XG; Klein B; Bataille R
Blood; 1989 Jul; 74(1):11-3. PubMed ID: 2787674
[TBL] [Abstract][Full Text] [Related]
2. Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.
Bataille R; Barlogie B; Lu ZY; Rossi JF; Lavabre-Bertrand T; Beck T; Wijdenes J; Brochier J; Klein B
Blood; 1995 Jul; 86(2):685-91. PubMed ID: 7605999
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-21 is a growth and survival factor for human myeloma cells.
Brenne AT; Ro TB; Waage A; Sundan A; Borset M; Hjorth-Hansen H
Blood; 2002 May; 99(10):3756-62. PubMed ID: 11986233
[TBL] [Abstract][Full Text] [Related]
4. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.
Shimizu S; Yoshioka R; Hirose Y; Sugai S; Tachibana J; Konda S
J Exp Med; 1989 Jan; 169(1):339-44. PubMed ID: 2783335
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma.
Kawano M; Tanaka H; Ishikawa H; Nobuyoshi M; Iwato K; Asaoku H; Tanabe O; Kuramoto A
Blood; 1989 Jun; 73(8):2145-8. PubMed ID: 2786435
[TBL] [Abstract][Full Text] [Related]
6. Decrease in BSF-2/IL-6 response in advanced cases of multiple myeloma.
Asaoku H; Kawano M; Iwato K; Tanabe O; Tanaka H; Hirano T; Kishimoto T; Kuramoto A
Blood; 1988 Aug; 72(2):429-32. PubMed ID: 3261180
[TBL] [Abstract][Full Text] [Related]
7. BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cells.
Tanabe O; Kawano M; Tanaka H; Iwato K; Asaoku H; Ishikawa H; Nobuyoshi M; Hirano T; Kishimoto T; Kuramoto A
Am J Hematol; 1989 Aug; 31(4):258-62. PubMed ID: 2787116
[TBL] [Abstract][Full Text] [Related]
8. Response patterns of purified myeloma cells to hematopoietic growth factors.
Anderson KC; Jones RM; Morimoto C; Leavitt P; Barut BA
Blood; 1989 May; 73(7):1915-24. PubMed ID: 2713508
[TBL] [Abstract][Full Text] [Related]
9. Lack of a role of interleukin 11 in the growth of multiple myeloma.
Paul SR; Barut BA; Bennett F; Cochran MA; Anderson KC
Leuk Res; 1992; 16(3):247-52. PubMed ID: 1532843
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells.
Zhang XG; Bataille R; Jourdan M; Saeland S; Banchereau J; Mannoni P; Klein B
Blood; 1990 Dec; 76(12):2599-605. PubMed ID: 2265252
[TBL] [Abstract][Full Text] [Related]
11. Mouse anti-human interleukin-6 receptor monoclonal antibody inhibits proliferation of fresh human myeloma cells in vitro.
Goto H; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Ashihara E; Oku N; Inaba T; Fujita N; Koishihara Y
Jpn J Cancer Res; 1994 Sep; 85(9):958-65. PubMed ID: 7961126
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells.
Lu ZY; Zhang XG; Rodriguez C; Wijdenes J; Gu ZJ; Morel-Fournier B; Harousseau JL; Bataille R; Rossi JF; Klein B
Blood; 1995 May; 85(9):2521-7. PubMed ID: 7727780
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
Westendorf JJ; Ahmann GJ; Greipp PR; Witzig TE; Lust JA; Jelinek DF
Leukemia; 1996 May; 10(5):866-76. PubMed ID: 8656685
[TBL] [Abstract][Full Text] [Related]
14. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.
Uchiyama H; Barut BA; Mohrbacher AF; Chauhan D; Anderson KC
Blood; 1993 Dec; 82(12):3712-20. PubMed ID: 8260708
[TBL] [Abstract][Full Text] [Related]
15. [Cytokines and lymphoplasmocytic proliferations: essential role of interleukin 6].
Bataille R; Klein B
Rev Prat; 1993 Feb; 43(3):275-8. PubMed ID: 8502954
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein.
Urashima M; Ogata A; Chauhan D; Vidriales MB; Teoh G; Hoshi Y; Schlossman RL; DeCaprio JA; Anderson KC
Blood; 1996 Sep; 88(6):2219-27. PubMed ID: 8822942
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined antigrowth factor receptor treatment on in vitro growth of multiple myeloma.
Taetle R; Dos Santos B; Ohsugi Y; Koishihara Y; Yamada Y; Messner H; Dalton W
J Natl Cancer Inst; 1994 Mar; 86(6):450-5. PubMed ID: 8120920
[TBL] [Abstract][Full Text] [Related]
18. Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease.
Hitzler JK; Martinez-Valdez H; Bergsagel DB; Minden MD; Messner HA
Blood; 1991 Oct; 78(8):1996-2004. PubMed ID: 1912582
[TBL] [Abstract][Full Text] [Related]
19. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.
Klein B; Zhang XG; Jourdan M; Content J; Houssiau F; Aarden L; Piechaczyk M; Bataille R
Blood; 1989 Feb; 73(2):517-26. PubMed ID: 2783861
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]